These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 22134529

  • 21. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR, Lee ST, Kim SL, Liu YC, Lee MR, Shin JH, Seo SY, Kim SH, Kim IH, Lee SO, Kim SW.
    Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.
    Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, Yang AG, Zhang R.
    Biochem Biophys Res Commun; 2012 Apr 20; 420(4):787-92. PubMed ID: 22459450
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
    Xu X, Chen R, Li Z, Huang N, Wu X, Li S, Li Y, Wu S.
    BMC Cancer; 2015 Dec 29; 15():1023. PubMed ID: 26714817
    [Abstract] [Full Text] [Related]

  • 24. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
    Yu L, Lu Y, Han X, Zhao W, Li J, Mao J, Wang B, Shen J, Fan S, Wang L, Wang M, Li L, Tang J, Song B.
    Stem Cell Res Ther; 2016 Dec 01; 7(1):180. PubMed ID: 27906093
    [Abstract] [Full Text] [Related]

  • 25. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.
    Sun L, Liu B, Lin Z, Yao Y, Chen Y, Li Y, Chen J, Yu D, Tang Z, Wang B, Zeng S, Fan S, Wang Y, Li Y, Song E, Li J.
    Mol Cancer; 2015 Apr 29; 14():96. PubMed ID: 25924850
    [Abstract] [Full Text] [Related]

  • 26. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
    Li W, Chang J, Tong D, Peng J, Huang D, Guo W, Zhang W, Li J.
    Oncotarget; 2017 May 30; 8(22):35783-35791. PubMed ID: 28415758
    [Abstract] [Full Text] [Related]

  • 27. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.
    Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J, Rahbari N, Dutta S, Bork U, Fritzmann J, Reissfelder C, Koch M, Weitz J.
    Cancer Sci; 2011 Oct 30; 102(10):1799-807. PubMed ID: 21722265
    [Abstract] [Full Text] [Related]

  • 28. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S, Liu H, Hou S, Wu L, Yang Z, Shen J, Zhou L, Zheng SS, Jiang B.
    Clin Transl Oncol; 2018 Jun 30; 20(6):703-712. PubMed ID: 29071516
    [Abstract] [Full Text] [Related]

  • 29. MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.
    Zhang W, Zhang T, Jin R, Zhao H, Hu J, Feng B, Zang L, Zheng M, Wang M.
    J Exp Clin Cancer Res; 2014 Dec 31; 33(1):113. PubMed ID: 25551793
    [Abstract] [Full Text] [Related]

  • 30. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
    Tang JQ, Fan Q, Wu WH, Jia ZC, Li H, Yang YM, Liu YC, Wan YL.
    Chin Med J (Engl); 2010 Dec 31; 123(24):3559-65. PubMed ID: 22166631
    [Abstract] [Full Text] [Related]

  • 31. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.
    J Natl Cancer Inst; 2015 Mar 31; 107(3):. PubMed ID: 25663689
    [Abstract] [Full Text] [Related]

  • 32. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
    Liu M, Xu A, Yuan X, Zhang Q, Fang T, Wang W, Li C.
    J Transl Med; 2015 Jun 18; 13():195. PubMed ID: 26084278
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
    Wu L, Hui H, Wang LJ, Wang H, Liu QF, Han SX.
    Oncol Rep; 2015 May 18; 33(5):2309-18. PubMed ID: 25760058
    [Abstract] [Full Text] [Related]

  • 34. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J.
    Oncogene; 2013 Oct 17; 32(42):5078-88. PubMed ID: 23208495
    [Abstract] [Full Text] [Related]

  • 35. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H, Liu J, Chen Y, Ma C, Li B, Hao T.
    Cancer Med; 2016 Oct 17; 5(10):2932-2941. PubMed ID: 27592860
    [Abstract] [Full Text] [Related]

  • 36. Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.
    Lam CS, Ng L, Chow AK, Wan TM, Yau S, Cheng NS, Wong SK, Man JH, Lo OS, Foo DC, Poon JT, Pang RW, Law WL.
    Oncotarget; 2017 Apr 18; 8(16):26858-26870. PubMed ID: 28460469
    [Abstract] [Full Text] [Related]

  • 37. Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.
    Zhou J, Wang J, Wu S, Zhu S, Wang S, Zhou H, Tian X, Tang N, Nie S.
    Int J Mol Med; 2014 Nov 18; 34(5):1286-92. PubMed ID: 25174582
    [Abstract] [Full Text] [Related]

  • 38. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor.
    Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q, Liu J.
    Biochem Pharmacol; 2012 Aug 01; 84(3):320-30. PubMed ID: 22580051
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
    Zhang GJ, Li JS, Zhou H, Xiao HX, Li Y, Zhou T.
    J Exp Clin Cancer Res; 2015 Jul 30; 34(1):73. PubMed ID: 26223867
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.
    J Urol; 2013 Sep 30; 190(3):1059-68. PubMed ID: 23454155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.